| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:DGKα&ζ-IN-1
CAS:2830643-06-4
Package:5mg;50mg
|
DGKα&ζ-IN-1 manufacturers
- DGKα&ζ-IN-1
-
- $0.00 / 5mg
-
2025-10-27
- CAS:2830643-06-4
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | DGKα&ζ-IN-1 Basic information |
| Product Name: | DGKα&ζ-IN-1 | | Synonyms: | DGKα&ζ-IN-1;Pyrido[3,2-d]pyrimidine-6-carbonitrile, 4-[(2S,5R)-4-[(3-cyclopropyl-1,2,4-oxadiazol-5-yl)(4-fluorophenyl)methyl]-2,5-diethyl-1-piperazinyl]-1,2-dihydro-1-methyl-2-oxo- | | CAS: | 2830643-06-4 | | MF: | C29H31FN8O2 | | MW: | 542.61 | | EINECS: | | | Product Categories: | | | Mol File: | 2830643-06-4.mol |  |
| | DGKα&ζ-IN-1 Chemical Properties |
| Boiling point | 703.671±70.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.429±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 3.804±0.70(predicted) |
| | DGKα&ζ-IN-1 Usage And Synthesis |
| Uses | DGKα&ζ-IN-1 (Compound II) is a DGK target inhibitor. DGKα&ζ-IN-1 can enhance the function of T cells, and has a synergistic effect with PD-1, which has therapeutic effects IN both immune and tumor[1]. | | References | [1] Tu-Sekine B, et al. DGK-θ: Structure, Enzymology, and Physiological Roles. Front Cell Dev Biol. 2016 Sep 14;4:101. DOI:10.3389/fcell.2016.00101 |
| | DGKα&ζ-IN-1 Preparation Products And Raw materials |
|